These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17292454)

  • 1. Renal artery thrombosis following secondary cytoreduction in a patient with ovarian cancer.
    Zakashansky K; Schiff J; Roayaie S; Rahaman J; Nagarsheth NP
    Gynecol Oncol; 2007 May; 105(2):536-8. PubMed ID: 17292454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
    Tebes SJ; Sayer RA; Palmer JM; Tebes CC; Martino MA; Hoffman MS
    Gynecol Oncol; 2007 Sep; 106(3):482-7. PubMed ID: 17590420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
    Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
    Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary cytoreduction in epithelial ovarian cancer recurrence: a perspective from a regional cancer center in India.
    Rema PN; Suchetha S; Mathew AP; Mathew A; Sebastian P
    J Reprod Med; 2009 Aug; 54(8):506-10. PubMed ID: 19769197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Port site metastasis of ovarian carcinoma remote from laparoscopic surgery for benign disease.
    Carlson NL; Krivak TC; Winter WE; Macri CI
    Gynecol Oncol; 2002 Jun; 85(3):529-31. PubMed ID: 12051886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should pelvic and para-aortic lymphadenectomy be different depending on histological subtype in epithelial ovarian cancer?
    Roger N; Zafrani Y; Uzan C; Gouy S; Rey A; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
    Ann Surg Oncol; 2008 Jan; 15(1):333-8. PubMed ID: 17943386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term consequences following conservative management of epithelial ovarian cancer in an infertile patient.
    Moore MM; Tewari K; Rose GS; Fruehauf JP; DiSaia PJ
    Gynecol Oncol; 1999 Jun; 73(3):452-4. PubMed ID: 10366478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colon resection for ovarian cancer: intraoperative decisions.
    Hoffman MS; Zervose E
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S56-65. PubMed ID: 18835022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenectomy as part of cytoreductive surgery in ovarian cancer.
    Magtibay PM; Adams PB; Silverman MB; Cha SS; Podratz KC
    Gynecol Oncol; 2006 Aug; 102(2):369-74. PubMed ID: 16631919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of therapeutic efficacy between TP regimen and CBP regimen on epithelial ovarian cancer after optimal cytoreductive operation].
    Gao KF; Liu FY; Chen FJ; Feng YL
    Ai Zheng; 2007 Apr; 26(4):431-4. PubMed ID: 17430668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
    J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary debulking surgery in ovarian cancer patients with isolated nodal recurrence located in the region above and behind the renal vein.
    Kato K; Omatsu K; Takeshima N
    Gynecol Oncol; 2013 Jul; 130(1):226-8. PubMed ID: 23562521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of bowel surgery with cytoreduction for epithelial ovarian cancer.
    Cai HB; Zhou YF; Chen HZ; Hou HY
    Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):757-62. PubMed ID: 17889517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
    Fotiou S; Aliki T; Petros Z; Ioanna S; Konstantinos V; Vasiliki M; George C
    Gynecol Oncol; 2009 Aug; 114(2):178-82. PubMed ID: 19450872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serous psammocarcinoma of the ovary: an unusual finding.
    Rettenmaier MA; Goldstein BH; Epstein HD; Brown JV; Micha JP
    Gynecol Oncol; 2005 Nov; 99(2):510-1. PubMed ID: 16051342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robotic Tumor Debulking off External Iliac Vessels for the Management of Recurrent Ovarian Cancer.
    Mutlu L; Khadraoui W; Khader T; Menderes G
    J Minim Invasive Gynecol; 2020; 27(5):1021-1022. PubMed ID: 31610315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Video-assisted thoracoscopic surgery for recurrent ovarian cancer with a metastatic mediastinal mass.
    Ki KD; Lee JM; Tong SY; Lee SK; Kim DH; Kwak YT; Lim SJ
    Onkologie; 2009 May; 32(5):274-6. PubMed ID: 19420974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary debulking surgery for isolated para-aortic nodal recurrence in ovarian cancer involving the division of the left renal vein.
    Kato K; Usami T; Takeshima N
    Gynecol Oncol; 2015 Apr; 137(1):188-9. PubMed ID: 25680865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgery of abdominal aorta with horseshoe kidney].
    Lotina SL; Davidović LB; Kostić DM; Velimirović DV; Petrović PLj; Perisić-Savić MV; KovacevićN S
    Srp Arh Celok Lek; 1997; 125(1-2):36-44. PubMed ID: 17974353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of CA-125 in the management of patients with recurrent epithelial ovarian carcinoma selected for secondary cytoreduction.
    Mahner S; Woelber L; Jung S; Eulenburg CZ; Ihnen M; Schwarz J; Sehouli J; Jaenicke F
    Anticancer Res; 2009 Jul; 29(7):2817-21. PubMed ID: 19596967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.